Detalhe da pesquisa
1.
Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS.
Blood
; 112(8): 3434-43, 2008 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18474728
2.
p38alpha-selective MAP kinase inhibitor reduces tumor growth in mouse xenograft models of multiple myeloma.
Anticancer Res
; 28(6A): 3827-33, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19189670
3.
Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors.
Blood
; 108(13): 4170-7, 2006 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16940419
4.
Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes.
J Pharmacol Exp Ther
; 318(1): 99-107, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16603672
5.
Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation.
Exp Cell Res
; 312(10): 1909-23, 2006 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-16600214
6.
APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA.
J Immunol
; 172(1): 138-43, 2004 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14688319